Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 445-453 , June 2009

The diagnosis of vasculitis

  • David Jayne, MD, FRCP (Consultant in Nephrology and Vasculitis)

      Affiliations

    • Corresponding Author InformationTel.: +44 1223 586796; Fax: +44 1223 586506.

References 

  1. Wilder MS, Palinkas LA, Kao AS, et al. Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome. Pediatr Infect Dis J. 2007;26:256–260
  2. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res. 2003;26:231–239
  3. Takala JH, Kautiainen H, Malmberg H, Leirisalo-Repo M. Incidence of Wegener's granulomatosis in Finland 1981-2000. Clin Exp Rheumatol. 2008;26:S81–S85
  4. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore). 2007;86:61–68
  5. Andrews M, Edmunds M, Campbell A, et al. Systemic vasculitis in the 1980s–is there an increasing incidence of Wegener's granulomatosis and microscopic polyarteritis?. J R Coll Physicians Lond. 1990;24:284–288
  6. Henes JC, Muller M, Krieger J, et al. [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. Clin Exp Rheumatol. 2008;26:S47–S52
  7. Molloy ES, Langford CA. Vasculitis mimics. Curr Opin Rheumatol. 2008;20:29–34
  8. Pagnoux C, Cohen P, Guillevin L. Vasculitides secondary to infections. Clin Exp Rheumatol. 2006;24:S71–S81
  9. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37:187–192
  10. Hunder GG, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990;33:1065–1067
  11. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36–44
  12. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352:351–361
  13. Zeek PM, Smith CC, Weeter JC. Studies on periarteritis nodosa; the differentiation between the vascular lesions of periarteritis nodosa and of hypersensitivity. Am J Pathol. 1948;24:889–917
  14. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33:1094–1100
  15. Stewart C, Cohen D, Bhattacharyya I, et al. Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review. J Am Dent Assoc. 2007;138:338–348quiz 396, 398
  16. Lightfoot RWJ, Michel BA, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990;33:1088–1093
  17. Sunderkotter C, Bonsmann G, Sindrilaru A, Luger T. Management of leukocytoclastic vasculitis. J Dermatolog Treat. 2005;16:193–206
  18. Nishino H, Rubino FA, DeRemee RA, et al. Neurological involvement in Wegener's granulomatosis: an analysis of 324 consecutive patients at the Mayo Clinic. Ann Neurol. 1993;33:4–9
  19. Calabrese LH, Molloy ES, Singhal AB. Primary central nervous system vasculitis: progress and questions. Ann Neurol. 2007;62:430–432
  20. Korantzopoulos P, Papaioannides D, Siogas K. The heart in Wegener's granulomatosis. Cardiology. 2004;102:7–10
  21. Wiik A. Autoantibodies in vasculitis. Arthritis Res Ther. 2003;5:147–152
  22. Hagen EC, Daha MR, Hermans J, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int. 1998;53:743–753
  23. Choi HK, Liu S, Merkel PA, et al. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. J Rheumatol. 2001;28:1584–1590
  24. Jayne D. Update on the European Vasculitis Study Group trials. Curr Opin Rheumatol. 2001;13:48–55

PII: S1521-6942(09)00026-6

doi: 10.1016/j.berh.2009.03.001

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 3 , Pages 445-453 , June 2009

Article Tools

* Image Usage & Resolution